Insider Transactions in Q1 2023 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2023
|
Grant Pickering |
BUY
Open market or private purchase
|
Direct |
15,000
+36.78%
|
$30,000
$2.47 P/Share
|
|
Mar 29
2023
|
Grant Pickering |
BUY
Open market or private purchase
|
Direct |
10,000
+48.12%
|
$20,000
$2.33 P/Share
|
|
Mar 29
2023
|
James A Johnson |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$10,000
$2.4 P/Share
|
|
Mar 24
2023
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,410
+8.56%
|
$6,410
$1.35 P/Share
|
|
Jan 05
2023
|
Andrew Gengos CFO and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,208
-1.42%
|
$2,416
$2.91 P/Share
|
|
Jan 05
2023
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,412
-2.92%
|
$4,824
$2.91 P/Share
|
|
Jan 04
2023
|
Andrew Gengos CFO and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+5.55%
|
-
|
|
Jan 04
2023
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.79%
|
-
|